\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ had\\ significant\\ pain\\ to\\ palpation\\ of\\ the\\ left\\ knee\\ and\\ on\\ weightbearing\\.\\ \\ she\\ had\\ an\\ elevated\\ wbc\\ with\\ a\\ left\\ shift\\ and\\ eleveated\\ esr\\ and\\ c\\-reactive\\ protein\\.\\ a\\ joint\\ aspirate\\ of\\ the\\ left\\ knee\\ revealed\\ polymorphonucleated\\ and\\ mononucleated\\ white\\ blood\\ cells\\.\ \(0\)\
\-\ systemic\\ antibiotics\\ \\(vancomycin\\)\\ and\\ surgical\\ debridement\ \(0\)\
\-\ 1\\)\\ anteroposterior\\ radiograph\\ of\\ the\\ left\\ knee\\ demonstrates\\ areas\\ of\\ osteolysis\\ in\\ the\\ distal\\ metaphysis\\ of\\ the\\ femur\\.\ \(0\)\
\-\ 2\\)\\ lateral\\ radiograph\\ of\\ the\\ left\\ knee\\ demonstrates\\ extensive\\ cortical\\ thickening\\ \\ with\\ foci\\ of\\ osteolysis\\ in\\ the\\ visualized\\ distal\\ femur\\ and\\ some\\ deformity\\ of\\ the\\ femur\\ most\\ marked\\ in\\ the\\ distal\\ metadiaphysis\\ and\\ the\\ medial\\ femoral\\ condyle\ \(0\)\
\-\ 3\\)\\ 3\\-phase\\ methylene\\ diphosphonate\\ \\(mdp\\)\\ 99\\-m\\ bone\\ scintigraphy\\ demonstrates\\ increased\\ radiopharmaceutical\\ uptake\\ in\\ the\\ distal\\ left\\ femur\\.\\ \\ the\\ 20\\-hour\\ delayed\\ fused\\ images\\ \\(99m\\ tc\\-mdp\\ with\\ 111\\-in\\-wbc\\)\\ showed\\ concordant\\ dual\\ tracer\\ accumulation\\ in\\ the\\ distal\\ left\\ femur\\ consistent\\ with\\ osteomyelitis\\.\ \(0\)\
\-\ 4\\)\\ axial\\ ct\\ of\\ the\\ left\\ knee\\ with\\ bone\\ windows\\ demonstrates\\ sclerotic\\ medullary\\ and\\ cortical\\ changes\\ of\\ the\\ left\\ mid\\ and\\ distal\\ femur\\ with\\ cortical\\ lucencies\\ and\\ acute\\ nonfatty\\ medullary\\ inflammatory\\ changes\\.\\ \\ an\\ osseous\\ sequestrum\\ is\\ present\\ in\\ the\\ distal\\ posterior\\ femur\\.\\ \\ at\\ the\\ level\\ of\\ the\\ condyles\\,\\ the\\ medullary\\ canal\\ communicates\\ through\\ a\\ cortical\\ defect\\ into\\ the\\ soft\\ tissues\\.\ \(0\)\
\-\ acute\\ on\\ chronic\\ osteomyelitis\ \(0\)\
\-\ post\\-traumatic\\ \\ changes\\ with\\ deformity\\ after\\ trauma\ \(0\)\
\-\ acute\\ on\\ chronic\\ osteomyelitis\ \(0\)\
\-\ post\\-traumatic\\ \\ changes\\ with\\ deformity\\ after\\ trauma\ \(0\)\
\-\ 82\\ y\\/o\\ female\\ with\\ significant\\ left\\ knee\\ pain\\ for\\ four\\ days\\;\\ the\\ patient\\ is\\ asplenic\\ and\\ has\\ a\\ prior\\ history\\ of\\ osteomyelitis\\ in\\ the\\ same\\ knee\\.\ \(1\)\
\-\ osteomyelitis\\,\\ an\\ infectious\\ process\\ that\\ produces\\ bony\\ destruction\\,\\ can\\ be\\ limited\\ to\\ a\\ single\\ area\\ of\\ bone\\ or\\ can\\ involve\\ multiple\\ areas\\,\\ including\\ the\\ marrow\\,\\ cortex\\,\\ periosteum\\,\\ and\\ surrounding\\ soft\\ tissue\\.\\ \\ osteomyelitis\\ may\\ spread\\ by\\ a\\ hematogenous\\ route\\,\\ from\\ a\\ contiguous\\ contaminated\\ source\\ \\(e\\.g\\.\\ following\\ trauma\\,\\ bone\\ surgery\\,\\ or\\ joint\\ replacement\\)\\,\\ or\\ be\\ a\\ complication\\ of\\ vascular\\ insufficiency\\ \\(predominantly\\ in\\ diabetic\\ patients\\)\\.\\ \\ staphylococcus\\ aureus\\ is\\ by\\ far\\ the\\ common\\ pathogen\\ causing\\ osteomyelitis\\.\\ \\ the\\ infection\\ may\\ be\\ acute\\ or\\ chronic\\;\\ acute\\ infections\\ tend\\ to\\ evolve\\ over\\ several\\ days\\ to\\ weeks\\.\\ acute\\ infection\\ may\\ resolve\\ with\\ appropriate\\ treatment\\.\\ osteomyelitis\\ that\\ is\\ untreated\\ or\\ insufficiently\\ treated\\ may\\ give\\ rise\\ to\\ a\\ chronic\\ infection\\ which\\ may\\ be\\ characterized\\ by\\ a\\ sequestrum\\ \\(necrotic\\ bone\\,\\ bacteria\\,\\ and\\ granulation\\ that\\ have\\ been\\ walled\\ off\\ by\\ new\\ reactive\\ bone\\ or\\ fibrous\\ tissue\\)\\.\\ \\ chronic\\ osteomyelitis\\ is\\ also\\ characterized\\ by\\ the\\ persistence\\ of\\ microorganisms\\,\\ low\\-grade\\ inflammation\\,\\ and\\ fistulous\\ tracts\\.\\ \\ recurrent\\ osteomyelitis\\ in\\ the\\ same\\ area\\ along\\ with\\ the\\ presence\\ of\\ fever\\ is\\ indicative\\ of\\ a\\ chronic\\ infection\\.\\ \\ the\\ diagnosis\\ of\\ osteomyelitis\\ is\\ based\\ on\\ clinical\\,\\ laboratory\\,\\ and\\ imaging\\ findings\\,\\ and\\ when\\ possible\\,\\ identification\\ of\\ the\\ offending\\ organism\\ by\\ blood\\ culture\\ or\\ direct\\ bone\\ biopsy\\.\ \(0\)\
\-\ plain\\ radiographs\\ should\\ be\\ the\\ first\\ imaging\\ modality\\ for\\ evaluating\\ osteomyelitis\\.\\ initially\\ they\\ may\\ be\\ normal\\ or\\ only\\ show\\ periosteal\\ reaction\\ and\\ soft\\ tissue\\ swelling\\.\\ \\ bone\\ destruction\\ \\(osteolytic\\ foci\\ on\\ the\\ radiographs\\)\\ may\\ not\\ be\\ visible\\ until\\ 10\\-21\\ days\\ after\\ the\\ infection\\ has\\ begun\\.\\ \\ with\\ chronicity\\,\\ reactive\\ osteosclerosis\\ as\\ well\\ as\\ areas\\ of\\ osteolysis\\ and\\ sequestra\\ and\\ involucra\\ may\\ occur\\.\\ differentiation\\ of\\ acute\\ osteomyelitis\\ from\\ inactive\\ chronic\\ osteomyelitis\\ can\\ be\\ difficult\\,\\ but\\ certain\\ indications\\ on\\ the\\ radiograph\\ aid\\ in\\ distinguishing\\ between\\ the\\ two\\,\\ including\\ a\\ change\\ from\\ a\\ previous\\ radiograph\\,\\ poorly\\ defined\\ areas\\ of\\ osteolysis\\,\\ \\ and\\ thin\\ and\\ linear\\ periostitis\\.\\ \\ although\\ ct\\ is\\ useful\\ for\\ evaluating\\ cortical\\ destruction\\,\\ sequestration\\,\\ cloacae\\,\\ and\\ bone\\ and\\ soft\\ tissue\\ abscesses\\,\\ \\ mr\\ imaging\\ \\(t1\\-weighted\\,\\ t2\\-weighted\\ with\\ fat\\ sat\\ and\\ post\\ contrast\\ sequences\\)\\ is\\ the\\ best\\ modality\\ for\\ evaluating\\ osteomyelitis\\,\\ cellulitis\\ and\\ areas\\ of\\ necrosis\\ for\\ debridement\\.\\ tc\\ 99m\\ \\â\\€\\“bone\\ scintigraphy\\ may\\ also\\ be\\ useful\\ for\\ diagnosing\\ osteomyelitis\\ but\\ does\\ not\\ have\\ the\\ resolution\\ of\\ mri\\.\\ \\ dual\\ isotope\\ bone\\-granulocyte\\ scintigraphy\\ \\(tc\\ 99m\\ mdpbone\\ and\\ white\\ blood\\ cells\\ labeled\\ with\\ indium\\-111\\)\\ has\\ a\\ high\\ sensitivity\\ \\(84\\%\\)\\ and\\ specificity\\ \\(71\\%\\)\\ in\\ detecting\\ areas\\ of\\ acute\\ infection\\.\\ however\\,\\ mri\\ has\\ increased\\ sensitivity\\ and\\ accuracy\\ in\\ the\\ detection\\ of\\ osteomyelitis\\ as\\ compared\\ to\\ three\\-phase\\ bone\\ scintigraphy\\.\\ \\ in\\ cases\\ of\\ acute\\ osteomyelitis\\,\\ the\\ process\\ is\\ identified\\ as\\ area\\(s\\)\\ of\\ low\\ signal\\ intensity\\ on\\ t1\\-weighted\\ images\\ and\\ high\\ signal\\ intensity\\ images\\ in\\ the\\ medullary\\ canal\\ on\\ fat\\-saturated\\ t2\\-weighted\\ \\ mr\\ images\\ or\\ stir\\ \\(short\\ tau\\ inversion\\ recovery\\)\\ mr\\ images\\.\\ cellulitis\\ shows\\ similar\\ findings\\ \\(low\\-signal\\-intensity\\ \\ foci\\ on\\ t1\\-weighted\\ images\\ and\\ high\\-signal\\-intensity\\ foci\\ on\\ fat\\-saturated\\ t2\\-weighted\\ or\\ stir\\ mr\\ images\\)\\.\\ contrast\\-enhanced\\ t1\\-weighted\\ \\ mr\\ imaging\\ shows\\ not\\ only\\ the\\ enhancement\\ of\\ areas\\ of\\ osteomyelitis\\ and\\ cellulitis\\,\\ but\\ also\\ shows\\ non\\-enhancing\\ areas\\ of\\ necrosis\\ important\\ for\\ debridement\\.\\ \\ active\\ and\\ inactive\\ phases\\ of\\ osteomyelitis\\ may\\ be\\ differentiated\\ by\\ \\ in\\ the\\ acute\\ phase\\ the\\ presence\\ of\\ periosteal\\ bone\\ formation\\ with\\ subperiosteal\\ fluid\\ and\\ areas\\ of\\ high\\ signal\\ intensity\\ areas\\ on\\ t2\\-weighted\\ and\\ stir\\ mr\\ images\\ that\\ enhance\\ after\\ contrast\\ media\\.\\ \\ bone\\ sclerosis\\ is\\ low\\ signal\\ intensity\\ on\\ mr\\ sequences\\.\\ abscesses\\ and\\ tracts\\ can\\ also\\ be\\ demonstrated\\ on\\ mri\\.\\ \\ for\\ definitive\\ histologic\\ diagnosis\\,\\ fluoroscopy\\ and\\/or\\ ct\\ is\\ used\\ to\\ biopsy\\ appendicular\\ and\\ axial\\ lesions\\ and\\ fluoroscopy\\ can\\ be\\ sometimes\\ use\\ for\\ biopsying\\ appendicular\\ lesions\\.\\ \\ \\ deep\\ abscesses\\ can\\ be\\ drained\\ with\\ ct\\ guidance\\ and\\ superficial\\ abscesses\\ with\\ sonographic\\ or\\ ct\\ guidance\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.4312214309881229\ \(0\)\
\-\ the\\:\\ 0\\.21957291114781735\ \(0\)\
\-\ and\\:\\ 0\\.2015480482622588\ \(0\)\
\-\ bone\\:\\ 0\\.19104317049216535\ \(0\)\
\-\ areas\\:\\ 0\\.16979688745153537\ \(0\)\
\-\ of\\:\\ 0\\.16640417976693309\ \(0\)\
\-\ femur\\:\\ 0\\.1436245798159757\ \(0\)\
\-\ acute\\:\\ 0\\.1352916157499904\ \(0\)\
\-\ be\\:\\ 0\\.13188939410513223\ \(0\)\
\-\ may\\:\\ 0\\.12585548760447657\ \(0\)\
\-\ knee\\:\\ 0\\.12548534985473417\ \(0\)\
\-\ osteolysis\\:\\ 0\\.12245178883005792\ \(0\)\
\-\ mr\\:\\ 0\\.11327582335318297\ \(0\)\
\-\ intensity\\:\\ 0\\.10655022603777396\ \(0\)\
\-\ or\\:\\ 0\\.10440414874477916\ \(0\)\
\-\ chronic\\:\\ 0\\.10391430370912362\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.10388692254821644\ \(0\)\
\-\ distal\\:\\ 0\\.10171782338674382\ \(0\)\
\-\ abscesses\\:\\ 0\\.10154517291299259\ \(0\)\
\-\ in\\:\\ 0\\.09954467092553479\ \(0\)\
\-\ on\\:\\ 0\\.09819271973420177\ \(0\)\
\-\ images\\:\\ 0\\.09254832153375786\ \(0\)\
\-\ infection\\:\\ 0\\.0906429650576943\ \(0\)\
\-\ cortical\\:\\ 0\\.0897756699947564\ \(0\)\
\-\ medullary\\:\\ 0\\.08847421565433808\ \(0\)\
\-\ left\\:\\ 0\\.0853127218662606\ \(0\)\
\-\ signal\\:\\ 0\\.08506291018831355\ \(0\)\
\-\ stir\\:\\ 0\\.08481415939974526\ \(0\)\
\-\ with\\:\\ 0\\.08325180311234595\ \(0\)\
\-\ is\\:\\ 0\\.08218812569520173\ \(0\)\
\-\ debridement\\:\\ 0\\.08197021924773071\ \(0\)\
\-\ foci\\:\\ 0\\.08176440970611298\ \(0\)\
\-\ cellulitis\\:\\ 0\\.07874617161704739\ \(0\)\
\-\ can\\:\\ 0\\.07874503311289473\ \(0\)\
\-\ evaluating\\:\\ 0\\.07547249070506817\ \(0\)\
\-\ by\\:\\ 0\\.07434326973637778\ \(0\)\
\-\ sequestrum\\:\\ 0\\.07391325554372333\ \(0\)\
\-\ tc\\:\\ 0\\.07249301694788737\ \(0\)\
\-\ 99m\\:\\ 0\\.07197032019682999\ \(0\)\
\-\ destruction\\:\\ 0\\.06840176594773054\ \(0\)\
\-\ for\\:\\ 0\\.06822157787151177\ \(0\)\
\-\ inactive\\:\\ 0\\.06680258478423995\ \(0\)\
\-\ radiograph\\:\\ 0\\.06515632283278298\ \(0\)\
\-\ reactive\\:\\ 0\\.06439199676064533\ \(0\)\
\-\ phase\\:\\ 0\\.06420137307715962\ \(0\)\
\-\ deformity\\:\\ 0\\.06132330727958474\ \(0\)\
\-\ changes\\:\\ 0\\.06045869834387207\ \(0\)\
\-\ tracts\\:\\ 0\\.058575333720908\ \(0\)\
\-\ appendicular\\:\\ 0\\.058575333720908\ \(0\)\
\-\ mdp\\:\\ 0\\.05750029085123381\ \(0\)\
\-\ dual\\:\\ 0\\.05750029085123381\ \(0\)\
\-\ low\\:\\ 0\\.0574022537259893\ \(0\)\
\-\ high\\:\\ 0\\.056854953165103424\ \(0\)\
\-\ fluoroscopy\\:\\ 0\\.05624550595829834\ \(0\)\
\-\ guidance\\:\\ 0\\.05624550595829834\ \(0\)\
\-\ soft\\:\\ 0\\.05325801675249951\ \(0\)\
\-\ imaging\\:\\ 0\\.05257326996368507\ \(0\)\
\-\ tissue\\:\\ 0\\.0524775955751947\ \(0\)\
\-\ sensitivity\\:\\ 0\\.050772586456496294\ \(0\)\
\-\ demonstrates\\:\\ 0\\.050257922549427445\ \(0\)\
\-\ modality\\:\\ 0\\.049465762621760244\ \(0\)\
\-\ area\\:\\ 0\\.04860446926611442\ \(0\)\
\-\ after\\:\\ 0\\.04852999566534388\ \(0\)\
\-\ useful\\:\\ 0\\.04775536688969626\ \(0\)\
\-\ ct\\:\\ 0\\.047606680731578525\ \(0\)\
\-\ days\\:\\ 0\\.04749620948697668\ \(0\)\
\-\ also\\:\\ 0\\.047054932502874264\ \(0\)\
\-\ fat\\:\\ 0\\.046672281205107795\ \(0\)\
\-\ characterized\\:\\ 0\\.04595550978840711\ \(0\)\
\-\ has\\:\\ 0\\.045694370047873106\ \(0\)\
\-\ shows\\:\\ 0\\.04403516798620682\ \(0\)\
\-\ periosteal\\:\\ 0\\.044016965654998436\ \(0\)\
\-\ to\\:\\ 0\\.043766210728484134\ \(0\)\
\-\ blood\\:\\ 0\\.04357361873689303\ \(0\)\
\-\ trauma\\:\\ 0\\.04357361873689303\ \(0\)\
\-\ that\\:\\ 0\\.043412670599574404\ \(0\)\
\-\ post\\:\\ 0\\.04082533576240356\ \(0\)\
\-\ as\\:\\ 0\\.04018875035184586\ \(0\)\
\-\ sequences\\:\\ 0\\.04001427908649693\ \(0\)\
\-\ eleveated\\:\\ 0\\.039995570759966535\ \(0\)\
\-\ asplenic\\:\\ 0\\.039995570759966535\ \(0\)\
\-\ insufficiently\\:\\ 0\\.039995570759966535\ \(0\)\
\-\ involucra\\:\\ 0\\.039995570759966535\ \(0\)\
\-\ cloacae\\:\\ 0\\.039995570759966535\ \(0\)\
\-\ mdpbone\\:\\ 0\\.039995570759966535\ \(0\)\
\-\ biopsying\\:\\ 0\\.039995570759966535\ \(0\)\
\-\ same\\:\\ 0\\.03956680771907058\ \(0\)\
\-\ cells\\:\\ 0\\.03853887144902911\ \(0\)\
\-\ mri\\:\\ 0\\.03851291267400815\ \(0\)\
\-\ canal\\:\\ 0\\.038500158203111805\ \(0\)\
\-\ necrosis\\:\\ 0\\.038233848139330937\ \(0\)\
\-\ polymorphonucleated\\:\\ 0\\.03821790307009569\ \(0\)\
\-\ mononucleated\\:\\ 0\\.03821790307009569\ \(0\)\
\-\ contaminated\\:\\ 0\\.03821790307009569\ \(0\)\
\-\ process\\:\\ 0\\.03751471287004876\ \(0\)\
\-\ but\\:\\ 0\\.037101650822669766\ \(0\)\
\-\ nonfatty\\:\\ 0\\.036956627771861664\ \(0\)\
\-\ microorganisms\\:\\ 0\\.036956627771861664\ \(0\)\
\-\ tau\\:\\ 0\\.036956627771861664\ \(0\)\
\-\ contrast\\:\\ 0\\.03645475763150363\ \(0\)\
\-\ sequestra\\:\\ 0\\.03597830664522976\ \(0\)\
\-\ isotope\\:\\ 0\\.03597830664522976\ \(0\)\
\-\ presence\\:\\ 0\\.035939064529389574\ \(0\)\
\-\ including\\:\\ 0\\.03579601835610546\ \(0\)\
\-\ wbc\\:\\ 0\\.03535334841607694\ \(0\)\
\-\ methylene\\:\\ 0\\.03517896008199082\ \(0\)\
\-\ pathogen\\:\\ 0\\.03517896008199082\ \(0\)\
\-\ biopsy\\:\\ 0\\.03506147912433512\ \(0\)\
\-\ concordant\\:\\ 0\\.03450312219256276\ \(0\)\
\-\ osteosclerosis\\:\\ 0\\.03450312219256276\ \(0\)\
\-\ evolve\\:\\ 0\\.033401292392119974\ \(0\)\
\-\ fistulous\\:\\ 0\\.033401292392119974\ \(0\)\
\-\ white\\:\\ 0\\.03300106600366236\ \(0\)\
\-\ joint\\:\\ 0\\.03295989909256856\ \(0\)\
\-\ communicates\\:\\ 0\\.03293936365712489\ \(0\)\
\-\ diphosphonate\\:\\ 0\\.03252149828778531\ \(0\)\
\-\ offending\\:\\ 0\\.03252149828778531\ \(0\)\
\-\ chronicity\\:\\ 0\\.03252149828778531\ \(0\)\
\-\ radiographs\\:\\ 0\\.03244160748491736\ \(0\)\
\-\ condyles\\:\\ 0\\.03146417920445789\ \(0\)\
\-\ granulation\\:\\ 0\\.03146417920445789\ \(0\)\
\-\ begun\\:\\ 0\\.03146417920445789\ \(0\)\
\-\ only\\:\\ 0\\.031248983497105056\ \(0\)\
\-\ route\\:\\ 0\\.030878741795651928\ \(0\)\
\-\ weightbearing\\:\\ 0\\.03061294720751448\ \(0\)\
\-\ aspirate\\:\\ 0\\.03061294720751448\ \(0\)\
\-\ periostitis\\:\\ 0\\.03061294720751448\ \(0\)\
\-\ metadiaphysis\\:\\ 0\\.0303623494040151\ \(0\)\
\-\ radiopharmaceutical\\:\\ 0\\.0303623494040151\ \(0\)\
\-\ distinguishing\\:\\ 0\\.0303623494040151\ \(0\)\
\-\ staphylococcus\\:\\ 0\\.030125304217114266\ \(0\)\
\-\ vancomycin\\:\\ 0\\.029900420669020017\ \(0\)\
\-\ from\\:\\ 0\\.02979809139835565\ \(0\)\
\-\ give\\:\\ 0\\.02968651151458704\ \(0\)\
\-\ organism\\:\\ 0\\.02968651151458704\ \(0\)\
\-\ not\\:\\ 0\\.02961941942285656\ \(0\)\
\-\ periosteum\\:\\ 0\\.029482555299680444\ \(0\)\
\-\ subperiosteal\\:\\ 0\\.029482555299680444\ \(0\)\
\-\ osteolytic\\:\\ 0\\.029287666860454\ \(0\)\
\-\ labeled\\:\\ 0\\.029287666860454\ \(0\)\
\-\ accuracy\\:\\ 0\\.029287666860454\ \(0\)\
\-\ anteroposterior\\:\\ 0\\.02910107410578108\ \(0\)\
\-\ persistence\\:\\ 0\\.02910107410578108\ \(0\)\
\-\ aureus\\:\\ 0\\.02892209954238811\ \(0\)\
\-\ untreated\\:\\ 0\\.02892209954238811\ \(0\)\
\-\ indications\\:\\ 0\\.02892209954238811\ \(0\)\
\-\ detecting\\:\\ 0\\.02892209954238811\ \(0\)\
\-\ axial\\:\\ 0\\.028892726677389804\ \(0\)\
\-\ significant\\:\\ 0\\.028879822280716436\ \(0\)\
\-\ tracer\\:\\ 0\\.028750145425616904\ \(0\)\
\-\ phases\\:\\ 0\\.028750145425616904\ \(0\)\
\-\ lesions\\:\\ 0\\.028726432900637006\ \(0\)\
\-\ an\\:\\ 0\\.028690600406893\ \(0\)\
\-\ specificity\\:\\ 0\\.028584681714144255\ \(0\)\
\-\ hematogenous\\:\\ 0\\.02842523621635302\ \(0\)\
\-\ rise\\:\\ 0\\.02842523621635302\ \(0\)\
\-\ drained\\:\\ 0\\.02842523621635302\ \(0\)\
\-\ certain\\:\\ 0\\.02827138646658175\ \(0\)\
\-\ diagnosing\\:\\ 0\\.02812275297914917\ \(0\)\
\-\ histologic\\:\\ 0\\.027978993608926195\ \(0\)\
\-\ media\\:\\ 0\\.027839798807547056\ \(0\)\
\-\ bacteria\\:\\ 0\\.027704887609809593\ \(0\)\
\-\ identification\\:\\ 0\\.027704887609809593\ \(0\)\
\-\ aid\\:\\ 0\\.02757400421940961\ \(0\)\
\-\ inversion\\:\\ 0\\.02757400421940961\ \(0\)\
\-\ produces\\:\\ 0\\.027446915089721108\ \(0\)\
\-\ windows\\:\\ 0\\.027086361229009395\ \(0\)\
\-\ increased\\:\\ 0\\.027047853255074205\ \(0\)\
\-\ walled\\:\\ 0\\.026753218650230094\ \(0\)\
\-\ lucencies\\:\\ 0\\.02664756852648217\ \(0\)\
\-\ fused\\:\\ 0\\.026544404520168874\ \(0\)\
\-\ diabetic\\:\\ 0\\.026544404520168874\ \(0\)\
\-\ resolve\\:\\ 0\\.026443612311575573\ \(0\)\
\-\ sequestration\\:\\ 0\\.02634508528927832\ \(0\)\
\-\ detection\\:\\ 0\\.026062131117676208\ \(0\)\
\-\ 84\\:\\ 0\\.02597173063705411\ \(0\)\
\-\ diagnosis\\:\\ 0\\.025929453375382435\ \(0\)\
\-\ contiguous\\:\\ 0\\.02579633652953876\ \(0\)\
\-\ indicative\\:\\ 0\\.025711202437512033\ \(0\)\
\-\ tend\\:\\ 0\\.025545738726039387\ \(0\)\
\-\ 82\\:\\ 0\\.025465291184943662\ \(0\)\
\-\ far\\:\\ 0\\.025465291184943662\ \(0\)\
\-\ sat\\:\\ 0\\.025157496901689388\ \(0\)\
\-\ have\\:\\ 0\\.024987193934405447\ \(0\)\
\-\ had\\:\\ 0\\.024921264782028645\ \(0\)\
\-\ findings\\:\\ 0\\.024686343070428704\ \(0\)\
\-\ recovery\\:\\ 0\\.02460001453751101\ \(0\)\
\-\ necrotic\\:\\ 0\\.024345782860634532\ \(0\)\
\-\ condyle\\:\\ 0\\.024284463427805363\ \(0\)\
\-\ differentiation\\:\\ 0\\.024284463427805363\ \(0\)\
\-\ 71\\:\\ 0\\.024284463427805363\ \(0\)\
\-\ culture\\:\\ 0\\.024223989807263657\ \(0\)\
\-\ accumulation\\:\\ 0\\.024164338982629124\ \(0\)\
\-\ superficial\\:\\ 0\\.024164338982629124\ \(0\)\
\-\ insufficiency\\:\\ 0\\.02410548886441239\ \(0\)\
\-\ differentiated\\:\\ 0\\.02387768344484813\ \(0\)\
\-\ source\\:\\ 0\\.023822534692810277\ \(0\)\
\-\ sometimes\\:\\ 0\\.0234046693234707\ \(0\)\
\-\ protein\\:\\ 0\\.023209780884244257\ \(0\)\
\-\ metaphysis\\:\\ 0\\.022977754894203554\ \(0\)\
\-\ esr\\:\\ 0\\.022888276931833873\ \(0\)\
\-\ definitive\\:\\ 0\\.022844213566178367\ \(0\)\
\-\ complication\\:\\ 0\\.02271461985602845\ \(0\)\
\-\ poorly\\:\\ 0\\.02258874705814924\ \(0\)\
\-\ sonographic\\:\\ 0\\.022506795737934515\ \(0\)\
\-\ spread\\:\\ 0\\.02246638745208927\ \(0\)\
\-\ replacement\\:\\ 0\\.02246638745208927\ \(0\)\
\-\ enhance\\:\\ 0\\.022386671292758276\ \(0\)\
\-\ systemic\\:\\ 0\\.022193500490372012\ \(0\)\
\-\ infections\\:\\ 0\\.02208155565200583\ \(0\)\
\-\ direct\\:\\ 0\\.02204486700293943\ \(0\)\
\-\ visible\\:\\ 0\\.02204486700293943\ \(0\)\
\-\ involve\\:\\ 0\\.022008482827499218\ \(0\)\
\-\ shift\\:\\ 0\\.02197239811368806\ \(0\)\
\-\ appropriate\\:\\ 0\\.02197239811368806\ \(0\)\
\-\ predominantly\\:\\ 0\\.021901107632716455\ \(0\)\
\-\ short\\:\\ 0\\.021496118243199868\ \(0\)\
\-\ reaction\\:\\ 0\\.021276072953435678\ \(0\)\
\-\ important\\:\\ 0\\.021185046819158785\ \(0\)\
\-\ sclerotic\\:\\ 0\\.02097972585156304\ \(0\)\
\-\ off\\:\\ 0\\.020894591759536316\ \(0\)\
\-\ until\\:\\ 0\\.020811079368278394\ \(0\)\
\-\ marrow\\:\\ 0\\.020783591704705406\ \(0\)\
\-\ difficult\\:\\ 0\\.020756275304945344\ \(0\)\
\-\ causing\\:\\ 0\\.02054366307937214\ \(0\)\
\-\ cortex\\:\\ 0\\.02036572633536583\ \(0\)\
\-\ resolution\\:\\ 0\\.020291624267485594\ \(0\)\
\-\ four\\:\\ 0\\.02026719931306858\ \(0\)\
\-\ compared\\:\\ 0\\.020218753870108252\ \(0\)\
\-\ linear\\:\\ 0\\.020147074867892346\ \(0\)\
\-\ infectious\\:\\ 0\\.020123439942845607\ \(0\)\
\-\ best\\:\\ 0\\.020123439942845607\ \(0\)\
\-\ inflammation\\:\\ 0\\.020099931747228385\ \(0\)\
\-\ recurrent\\:\\ 0\\.020053290158635606\ \(0\)\
\-\ osseous\\:\\ 0\\.019961469672178097\ \(0\)\
\-\ limited\\:\\ 0\\.019961469672178097\ \(0\)\
\-\ formation\\:\\ 0\\.01982724690468127\ \(0\)\
\-\ tissues\\:\\ 0\\.01971845055332902\ \(0\)\
\-\ initially\\:\\ 0\\.019612288756828168\ \(0\)\
\-\ delayed\\:\\ 0\\.019570533508087507\ \(0\)\
\-\ visualized\\:\\ 0\\.019529172182658813\ \(0\)\
\-\ thin\\:\\ 0\\.019467852749829644\ \(0\)\
\-\ deep\\:\\ 0\\.019467852749829644\ \(0\)\
\-\ fibrous\\:\\ 0\\.0194274444639844\ \(0\)\
\-\ extensive\\:\\ 0\\.019269435724514554\ \(0\)\
\-\ bony\\:\\ 0\\.019269435724514554\ \(0\)\
\-\ uptake\\:\\ 0\\.01923080756292881\ \(0\)\
\-\ single\\:\\ 0\\.01923080756292881\ \(0\)\
\-\ use\\:\\ 0\\.01913570040662281\ \(0\)\
\-\ similar\\:\\ 0\\.01906107276687241\ \(0\)\
\-\ change\\:\\ 0\\.018951460358192822\ \(0\)\
\-\ marked\\:\\ 0\\.018915523534212456\ \(0\)\
\-\ previous\\:\\ 0\\.018897664984149503\ \(0\)\
\-\ used\\:\\ 0\\.018722969843232448\ \(0\)\
\-\ femoral\\:\\ 0\\.01858805864549498\ \(0\)\
\-\ active\\:\\ 0\\.018571482943412463\ \(0\)\
\-\ antibiotics\\:\\ 0\\.01842505593211024\ \(0\)\
\-\ occur\\:\\ 0\\.018393170206268537\ \(0\)\
\-\ defect\\:\\ 0\\.01834577225297476\ \(0\)\
\-\ laboratory\\:\\ 0\\.018161144216227835\ \(0\)\
\-\ based\\:\\ 0\\.018116176970973518\ \(0\)\
\-\ mid\\:\\ 0\\.01799847143232953\ \(0\)\
\-\ pain\\:\\ 0\\.01789861017893515\ \(0\)\
\-\ they\\:\\ 0\\.01786972348007925\ \(0\)\
\-\ defined\\:\\ 0\\.017841619101928306\ \(0\)\
\-\ sclerosis\\:\\ 0\\.01781369373376967\ \(0\)\
\-\ identified\\:\\ 0\\.017730969242231453\ \(0\)\
\-\ new\\:\\ 0\\.0173019432356088\ \(0\)\
\-\ does\\:\\ 0\\.017289575757792882\ \(0\)\
\-\ elevated\\:\\ 0\\.017049281761570743\ \(0\)\
\-\ although\\:\\ 0\\.01702596113223212\ \(0\)\
\-\ thickening\\:\\ 0\\.017014347170530734\ \(0\)\
\-\ fever\\:\\ 0\\.01695673441010913\ \(0\)\
\-\ possible\\:\\ 0\\.016945302153361597\ \(0\)\
\-\ inflammatory\\:\\ 0\\.016911183164217438\ \(0\)\
\-\ first\\:\\ 0\\.016877327644799538\ \(0\)\
\-\ palpation\\:\\ 0\\.01686610031989707\ \(0\)\
\-\ swelling\\:\\ 0\\.016832589828257614\ \(0\)\
\-\ cases\\:\\ 0\\.01682147634200648\ \(0\)\
\-\ along\\:\\ 0\\.016755380598067856\ \(0\)\
\-\ surrounding\\:\\ 0\\.016679507565224152\ \(0\)\
\-\ showed\\:\\ 0\\.016658068559283572\ \(0\)\
\-\ vascular\\:\\ 0\\.016510861081939502\ \(0\)\
\-\ plain\\:\\ 0\\.01650053300183118\ \(0\)\
\-\ several\\:\\ 0\\.016408659065312674\ \(0\)\
\-\ revealed\\:\\ 0\\.016398568685764385\ \(0\)\
\-\ should\\:\\ 0\\.016318670930609378\ \(0\)\
\-\ medial\\:\\ 0\\.016279261514889794\ \(0\)\
\-\ patient\\:\\ 0\\.016268643524862195\ \(0\)\
\-\ between\\:\\ 0\\.016249935198331802\ \(0\)\
\-\ show\\:\\ 0\\.015876580546107587\ \(0\)\
\-\ clinical\\:\\ 0\\.015849819926024824\ \(0\)\
\-\ some\\:\\ 0\\.01573570841206303\ \(0\)\
\-\ treated\\:\\ 0\\.015574097308903741\ \(0\)\
\-\ demonstrated\\:\\ 0\\.015370141093997142\ \(0\)\
\-\ level\\:\\ 0\\.015107160842949049\ \(0\)\
\-\ when\\:\\ 0\\.015107160842949049\ \(0\)\
\-\ following\\:\\ 0\\.015003298537999494\ \(0\)\
\-\ weeks\\:\\ 0\\.01498865990009778\ \(0\)\
\-\ she\\:\\ 0\\.01488753556257144\ \(0\)\
\-\ through\\:\\ 0\\.01488753556257144\ \(0\)\
\-\ two\\:\\ 0\\.014851977638721415\ \(0\)\
\-\ however\\:\\ 0\\.014802676113823436\ \(0\)\
\-\ been\\:\\ 0\\.014570794530758205\ \(0\)\
\-\ fluid\\:\\ 0\\.014439911140358218\ \(0\)\
\-\ enhancement\\:\\ 0\\.014395009685933347\ \(0\)\
\-\ common\\:\\ 0\\.014183228300519799\ \(0\)\
\-\ patients\\:\\ 0\\.014069188891682604\ \(0\)\
\-\ prior\\:\\ 0\\.013992836682444415\ \(0\)\
\-\ over\\:\\ 0\\.013906359165256729\ \(0\)\
\-\ consistent\\:\\ 0\\.013560703207289687\ \(0\)\
\-\ surgery\\:\\ 0\\.013446143369520975\ \(0\)\
\-\ into\\:\\ 0\\.013294598283425444\ \(0\)\
\-\ most\\:\\ 0\\.013015680190692108\ \(0\)\
\-\ posterior\\:\\ 0\\.012932607364706458\ \(0\)\
\-\ present\\:\\ 0\\.012833166096137836\ \(0\)\
\-\ lateral\\:\\ 0\\.012411645646987993\ \(0\)\
\-\ multiple\\:\\ 0\\.012232671083595024\ \(0\)\
\-\ surgical\\:\\ 0\\.012155413261067413\ \(0\)\
\-\ well\\:\\ 0\\.012109703710850146\ \(0\)\
\-\ female\\:\\ 0\\.012068217854844177\ \(0\)\
\-\ treatment\\:\\ 0\\.011913332736552696\ \(0\)\
\-\ which\\:\\ 0\\.01137205019339658\ \(0\)\
\-\ normal\\:\\ 0\\.010211194731986003\ \(0\)\
\-\ history\\:\\ 0\\.009555061450910732\ \(0\)\
\-\ at\\:\\ 0\\.009446389569528212\ \(0\)\
